online medicine

Online Drug Supplier 111 Finds Tonic in B2B Focus

Company adds two fulfillment centers, inks deal with cancer drug maker BeiGene, in drive to consolidate its place as premier B2B specialist Key takeaways 111 Inc.’s aggressive pursuit of partnerships…

Recent Articles

RELATED ARTICLES

  1. 160 Health readies IPO
    Margins ring alarm bells as 160 Health readies IPO 
  2. Inaugural operating profit fails to lift 111 Inc.
    YI.US
  3. Third time’s the charm: Fangzhou finally finds winning tonic for Hong Kong IPO
    6086.HK
  4. IFlytek hives off health unit to fund AI medical drive
    002230.SHE
  5. Slowing revenue growth hurts online drug platform YSB
    9885.HK
  6. HealthyWay seeks Hong Kong IPO to staunch flow of red ink
  7. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva